Zuozhang Yang

4.5k total citations · 1 hit paper
53 papers, 3.1k citations indexed

About

Zuozhang Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zuozhang Yang has authored 53 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 23 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zuozhang Yang's work include Cancer-related molecular mechanisms research (18 papers), Sarcoma Diagnosis and Treatment (14 papers) and RNA modifications and cancer (14 papers). Zuozhang Yang is often cited by papers focused on Cancer-related molecular mechanisms research (18 papers), Sarcoma Diagnosis and Treatment (14 papers) and RNA modifications and cancer (14 papers). Zuozhang Yang collaborates with scholars based in China, United States and Italy. Zuozhang Yang's co-authors include Zhenyi Su, Yongqing Xu, Qiang Yu, Yongbin Chen, Lin Xie, Yongbin Chen, Yihao Yang, Ya Zhang, Lei Han and Zewei He and has published in prestigious journals such as PLoS ONE, Scientific Reports and Cell Death and Differentiation.

In The Last Decade

Zuozhang Yang

52 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apoptosis, autophagy, necroptosis, and cancer metastasis

2015 794 citations Zhenyi Su, Zuozhang Yang et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Zuozhang Yang

Since Specialization

Citations

This map shows the geographic impact of Zuozhang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuozhang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuozhang Yang more than expected).

Fields of papers citing papers by Zuozhang Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuozhang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuozhang Yang. The network helps show where Zuozhang Yang may publish in the future.

Co-authorship network of co-authors of Zuozhang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zuozhang Yang. A scholar is included among the top collaborators of Zuozhang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuozhang Yang. Zuozhang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Telomeres and telomerase in Sarcoma disease and therapy 2024 ·International Journal of Medical Sciences ·Jin Huang, Feng Yan, (unknown), (unknown), (unknown), (unknown), Ying Li, Zuozhang Yang, Zhihong Yao	2
2	miR-137–LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma 2023 ·Oncogenesis ·(unknown), Dan Liu, (unknown), Minxia Liu, (unknown), Jing Bai, Shuo Yang, Jun Chang, Zhihong Yao, Zuozhang Yang, Tomas Blom, Kecheng Zhou	9
3	Low‐dose aspirin can inhibit exosomal release induced by radiotherapy in breast cancer and attenuate its inhibitory effect on NK cell proliferation 2023 ·Cancer Medicine ·(unknown), Zaoxiu Hu, Ceshi Chen, Ting Chen, Zhihong Yao, Wenhui Li, Zuozhang Yang	9
4	The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer 2023 ·Cell Death Discovery ·Yanan Zhu, Jing Li, Hang Yang, Xinyi Yang, Ya Zhang, (unknown), Ying Li, (unknown), Zuozhang Yang	26
5	Prognostic nomogram for predicting 5-year overall survival in Chinese patients with high-grade osteosarcoma 2021 ·Scientific Reports ·(unknown), (unknown), Jifei Yang, Yihao Yang, Cao Wang, (unknown), Yanan Zhu, (unknown), Lei Han, Lin Zhu, Zuozhang Yang	5
6	MicroRNA-106a regulates autophagy-related cell death and EMT by targeting TP53INP1 in lung cancer with bone metastasis 2021 ·Cell Death and Disease ·Lei Han, (unknown), Yan Liu, Lijuan Ye, Dongqi Li, Zhihong Yao, Cao Wang, Ya Zhang, Hang Yang, (unknown), (unknown), Zuozhang Yang	31
7	Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis 2021 ·Cell Death Discovery ·Yan Liu, Qiu‐Yun Chen, Yanan Zhu, (unknown), Lijuan Ye, Lei Han, Zhihong Yao, Zuozhang Yang	50
8	Transcriptome Sequencing reveals the expressed profiles of mRNA and ncRNAs and regulate network via ceRNA mediated molecular mechanism of lung adenocarcinoma bone metastasis in Xuanwei 2021 ·Translational Cancer Research ·Lei Han, Zhihong Yao, Lin Xie, Dongqi Li, Cao Wang, Yihao Yang, Jifei Yang, (unknown), Kecheng Li, Ya Zhang, Lijuan Ye, (unknown), Yan Liu, Qiuyun Chen, (unknown), Zuozhang Yang	4
9	GRK5 functions as an oncogenic factor in non-small-cell lung cancer 2018 ·Cell Death and Disease ·Liping Jiang, Songqing Fan, Qiuxia Xiong, Yongchun Zhou, Zuozhang Yang, Gaofeng Li, Yunchao Huang, Mengge Wu, Qiushuo Shen, Kun Liu, Cuiping Yang, Yongbin Chen	34
10	Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis 2018 ·Cell Death and Disease ·Lin Xie, Zhihong Yao, Ya Zhang, Dongqi Li, (unknown), Yedan Liao, Ling Zhou, Yonghong Zhou, (unknown), Zewei He, Lei Han, Yihao Yang, Zuozhang Yang	61
11	Does intensified chemotherapy increase survival outcomes of osteosarcoma patients? A meta-analysis 2018 ·Journal of bone oncology ·Ya Zhang, Zewei He, Yanping Duan, Cao Wang, (unknown), (unknown), Jifei Yang, (unknown), Na Zhao, Lei Han, Yihao Yang, Zuozhang Yang	16
12	Selection of Surgical Methods in the Treatment of Upper Tibia Osteosarcoma and Prognostic Analysis 2017 ·Oncology Research and Treatment ·(unknown), (unknown), Yi Li, Yihao Yang, (unknown), Xuefeng Liu, Tao Yuan, Junfeng Xia, Dongqi Li, Jing Zhang, Zuozhang Yang	7
13	Advances in limb salvage treatment of osteosarcoma 2017 ·Journal of bone oncology ·Yichun Yang, (unknown), Lei Han, Zewei He, Xiaojuan Li, (unknown), Jifei Yang, (unknown), Dongqi Li, (unknown), (unknown), Zuozhang Yang	75
14	Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone 2016 ·World Journal of Surgical Oncology ·Dongqi Li, Jinlei Zhang, Yi Li, Junfeng Xia, Yihao Yang, (unknown), Yedan Liao, (unknown), Xiaojuan Li, (unknown), (unknown), Zuozhang Yang	28
15	Thoracolumbar paravertebral giant ganglioneuroma and scoliosis: a case report and literature review 2016 ·World Journal of Surgical Oncology ·Yihao Yang, (unknown), (unknown), Kun Li, Zhiping Zhang, Jing Zhang, Lin Xie, Zuozhang Yang	20
16	P62: An emerging oncotarget for osteolytic metastasis 2016 ·Journal of bone oncology ·Jing Zhang, Zuozhang Yang, Jian Dong	28
17	Expression of ezrin, CD44, and VEGF in giant cell tumor of bone and its significance 2015 ·World Journal of Surgical Oncology ·Jing Zhang, Jian Dong, Zuozhang Yang, Xiang Ma, Jinlei Zhang, Mei Li, Yun Chen, Yingying Ding, Kun Li, Zhiping Zhang	15
18	Apoptosis, autophagy, necroptosis, and cancer metastasis breakdown → 2015 ·Molecular Cancer ·Zhenyi Su, Zuozhang Yang, Yongqing Xu, Yongbin Chen, Qiang Yu	794
19	Increased Levels of β-catenin, LEF-1, and HPA-1 Correlate with Poor Prognosis for Acral Melanoma with Negative BRAF and NRAS Mutation in BRAF Exons 11 and 15 and NRAS Exons 1 and 2 2014 ·DNA and Cell Biology ·(unknown), Zuozhang Yang, Jinyu Zhang, (unknown), Yongbin Chen, Hongjun Li, Xuefeng Liu, Da Xu, Yanjin Chen, Yihao Yang, Ya Zhang, Dongxu Li, Junfeng Xia	20
20	Clinical features of malignant melanoma of the finger and therapeutic efficacies of different treatments 2011 ·Oncology Letters ·Zuozhang Yang	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact